RIPK1-IN-3 (Example 38), a RIPK1 inhibitor, extracted from patent WO2018148626A1, possesses anti-inflammatory proprieties[1].
[1]. Guo Junqing, et al. Aminotriazolopyridines as kinase inhibitors. WO/2018/148626A1.
